trending Market Intelligence /marketintelligence/en/news-insights/trending/husm3qsb_-a_fffvgomqjq2 content esgSubNav
In This List

ImmunoGen board member to step down

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


ImmunoGen board member to step down

ImmunoGen Inc. said its board member Daniel Junius will not stand for re-election at the upcoming annual meeting of the company.

Junius is the former president and CEO of the Waltham, Mass.-based company that develops therapies for cancer.